Transcription by nonsegmented negative-strand RNA viruses is mediated by the viral RNA-dependent RNA polymerase and transcriptional cofactor P. The P protein is activated by phosphorylation, an event initiated by cellular kinases. The kinase used differs among this group of RNA viruses; vesicular stomatitis virus and respiratory syncytial virus utilize casein kinase II (CKII), whereas human parainfluenza virus type 3 utilizes PKC isoform zeta (PKC-z) for activation of its P protein.
INTRODUCTION
and the formation of an active polymerase complex (Das et al., 1995a; Gao and Lenard, 1995) . The role of LAK in The transcription and genomic replication of nonseg-VSV transcription/replication remains to be determined. mented negative-strand RNA viruses is mediated by a
The particular cellular kinase responsible for the P 0 virus-encoded RNA-dependent RNA polymerase comphosphorylation varies among negative-strand RNA viplex consisting of viral phosphoprotein (P) and RNA polyruses, illustrated by members of the paramyxovirus fammerase (L). The P protein is a transcription cofactor or a ily. Human parainfluenza virus type 3 (HPIV3) utilizes extransactivator for L (Curran et al., 1992; De et al., 1991;  clusively protein kinase C-z for P 0 phosphorylation (De Hamaguchi et al., 1983; Takacs et al., 1995) . In vesicular et al., 1995; Huntley et al., 1995) . In situ inhibition of stomatitis virus (VSV), a prototype for negative-strand PKC-z activity using an isoform-specific peptide inhibitor RNA viruses, P phosphorylation is initiated by cellular eliminates cellular permissiveness to HPIV3 replication. kinases (Barik and Banerjee, 1991, 1992 ; Gao and Len-Furthermore, PKC-z is incorporated into the HPIV3 virion ard, 1995; Gupta et al., 1995) . The initial phosphorylation (De et al., 1995) . For respiratory syncytial virus (RSV), of P (P 0 ) is mediated by casein kinase II (CKII), resulting CKII phosphorylates P 0 and is directly responsible for regin a structurally distinct form of P (P 1 ). The P 1 is then ulating viral transcriptional activity in reconstituted sysphosphorylated by an L-associated kinase (LAK) to betems (Barik et al., 1995; Mazumder and Barik, 1994 ; Vilcome the fully phosphorylated P 2 form (Barik and Banlanueva et al., 1994) . Casein kinase II was also shown erjee, 1992; Gao and Lenard, 1995) . The essential role to be the predominant source of measles virus (MV) P 0 of CKII in VSV transcription was demonstrated in reconphosphorylation using crude cell extracts as a source of stituted systems, where purified ribonucleoprotein temenzyme (Das et al., 1995b) . However, a reconstitution plates (i.e., N protein-encapsidated genomic RNA) were system to show the requirement of CKII-mediated P combined with purified native L protein and a nonphosphosphorylation for transcription is not currently availphorylated recombinant P protein. The addition of CKII able for MV. Protein kinase C recognition sites are preswas necessary and sufficient to support VSV transcripent within the deduced amino acid sequence of the MV tion (Gao and Lenard, 1995) . Phosphorylation of P by P gene although their recognition by cellular kinases has CKII results in P oligomerization which is, in turn, necesnot been established. sary for the association of P with template and L protein Analysis of the deduced amino acid sequence of the canine distemper virus P gene reveals multiple CKII and structural relatedness of canine distemper virus (CDV) AGT AAT ACT TTT GAC) primers. Primers were synthesized by Operon Technologies, Inc. (Alameda, CA). The and MV P proteins (Rima, 1983; Yamanaka et al., 1992) suggests similar kinase utilization for P 0 phosphorylation.
PCR incubation (Perkin-Elmer Thermal Cycler) consisted of 24 thermal cycles, each cycle including denatur-However, the heterogeneity of kinase utilization by the paramyxoviruses requires that this prediction be sub-ation at 94Њ for 2 min, annealing at 50Њ for 2 min, and elongation at 72Њ for 2 min. A 5-min initial denaturation stantiated and the potential relevance of PKC phosphorylation events be addressed. The objective of the present and an additional elongation period of 5 min following the last cycle were also incorporated. work was to identify cellular kinase(s) phosphorylating the CDV P protein, to compare these phosphorylation The CDV P gene cDNA was gel purified, restricted with HindIII and NdeI, then ligated into HindIII/NdeI linearized events to those of MV P protein, and to establish the relevance of these kinase activities to CDV replication.
pET-17b (Novagen) expression vector. This vector contains an ampicillin-resistance marker (bla) and a bacterial origin of replication, allowing its use in the amplifica-MATERIAL AND METHODS tion of the construct. The ligation reaction product was Virus-cell systems transformed into E. coli DH5-a for screening and amplification. Desired constructs were identified by restriction The Onderstepoort strain of canine distemper virus analysis using BamHI; restriction maps of the P gene (Ond-CDV) was used to infect continuous cell lines deand vector predict the release of a 4-and a 0.91-kb rived from African green monkey kidney: Vero (ATCC fragment following BamHI digestion. Desired constructs CCL81) and CV1 (ATCC CCL70). Both cell lines support were introduced into E. coli BL21(DE3) cells for the proequivalent degrees of cytopathic and productive infection duction of P protein. The DE3 cells contain a T7 RNA by Ond-CDV. CDV-infected cells were used as a source polymerase gene under control of a lacUV5 promoter; of viral nucleocapsid (NC)/genomic RNA for the producthe pET-17b vector contains a strong T7 RNA polymerase tion of a full-length P gene cDNA, while uninfected cells promoter directed at the polylinker. The pET-17b-CDVPwere used as a source of cellular kinases in the phoscontaining DE3 cells were grown at 37Њ in LB media phorylation of recombinant CDV and MV P protein. Cells containing 100 mg/ml ampicillin and 0.3% glucose. Prowere grown at 37Њ in complete Eagle's essential medium duction of P protein was then induced with 1 mM IPTG supplemented with 10% FCS.
for 2 hr and the recombinant P protein recovered by Niaffinity chromatography as previously described (De et Production of recombinant CDV P in Escherichia coli al., 1995) . Column fractions were resolved by 10% SDS-PAGE followed by both Coomassie staining and Western The production and characterization of recombinant P protein from the Edmonston strain of MV has been blot analysis using CDV P monospecific hyperimmune serum (Oglesbee et al., 1989b) . described (Das et al., 1995b) . For the production of a nonphosphorylated recombinant CDV P protein, the Ond-CDV NC was purified by CsCl isopycnic centrifugation as
Purification of cellular kinase activities previously described (Oglesbee et al., 1989a,b) . Genomic RNA was isolated by resuspending NC in TE buffer (10 The cellular kinase activities phosphorylating the recombinant CDV and MV P proteins were purified from mM Tris-HCl, pH 8.0, 1 mM EDTA) containing 0.6% SDS and 0.2 mg/ml proteinase K, incubating the mixture at cytoplasmic extracts of CV1 cells using DEAE-cellulose and phosphocellulose ion-exchange chromatography as 37Њ for 20 min, and then using two rounds of phenol/ chloroform extraction. The full-length genomic RNA was previously described (De et al., 1995) . Measurement of phosphorylation was based upon the incorporation of used as template for the reverse transcription (RT)-PCR amplification of the P gene. The initial RT reaction con-[g-32 P]ATP into nonphosphorylated recombinant P 0 (see below). Twenty million CV1 cells were disrupted into 10 tained 50 mM Tris-HCl (pH 8.5), 8 mM MgCl 2 , 30 mM KCl, 1 mM DTT, 1 mM dNTPs, 2 units/ml AMV reverse ml of 10 mM Tris-HCl, pH 7.5, 10 mM NaCl using two freeze-thaw cycles. The lysate was clarified at 10,000g transcriptase (Boehringer Mannheim, Germany), 1.25 U/ ml RNase inhibitor, and 25 ng/ml primer CDV-P5 (5-GCG for 10 min and then at 100,000 g for 1 hr (Beckman Ultracentrifuge, SW50 rotor). The clarified lysate was then CCA TAT GGC AGA GGA ACA GGC CTA C). The reaction was incubated at 37Њ for 30 min followed by heat inactiva-dialyzed against buffer A [50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5% v/v glycerol, 0.1 mM EDTA, 1 mM DTT] for tion at 85Њ for 10 min. The reaction product was then used as template for the PCR amplification of P gene 12 hr and then adsorbed to the DEAE-cellulose column (DE52). This column was developed using a linear gradi-cDNA. The reactions contained 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 50 mM KCl, 1 mM dNTPs, 0.01 U/ml Taq ent of 0-0.4 M NaCl in buffer A. The fractions supporting P phosphorylation were pooled and adsorbed onto the DNA polymerase (Boehringer Mannheim), and 5 ng/ml of both the 5 (CDV-P5) and 3 (CDVP3His; 5-CCC AAG phosphocellulose column and the column developed by a linear 0.2-1.0 M NaCl gradient. CTT TTA ATG ATG ATG ATG ATG ATG ATG AGC ATG In vitro phosphorylation of CDV and MV P using CV1-(Quality Controlled Biochemicals, Inc.) were delivered into cells using a lipid-based peptide delivery system origin kinase (TransPort transient cell permeabilization kit; Gibco BRL). In vitro phosphorylation of 1 mg CDV or MV P protein Subconfluent monolayers of cells in 24-well plates were was performed under reaction conditions optimal for either incubated at 37Њ, 15 min, with varying concentrations of CKII or PKC. The CKII reactions contained 50 mM Trispeptide A or Z (0, 1, 2, 3, 4, or 5 mM) in the peptide HCl (pH 7.5), 10 mM MgCl 2 , 100 mM NaCl, 2 mM DTT, delivery buffer system. The peptide-containing buffer was 33.3 mM ATP, and 10 mCi [g-32 P]ATP. PKC reactions differed then replaced by fresh MEM medium with 10% FCS. Cells in that the salt concentration was low (20 mM Tris-HCl were allowed to recover at 37Њ for 45 min, then infected and no NaCl), BSA was added (0.25% w/v), and PKC cofacwith Ond-CDV at a multiplicity of infection (m.o.i.) of 0.01. tors were added as indicated, including 0.1 mg/ml phospha-Viral progeny were harvested at 24 hr postinfection using tidylserine (PS), 0.5 mM CaCl 2 , 0.1 mg/ml diacylglycerol two freeze-thaw cycles and titrated in a plaque forming (DAG). The PS and DAG were dissolved in 10 mM CHAPS assay. prior to addition to the reactions; detergent does not influence kinase activity in these assays. For the analysis of RESULTS kinase activities within crude cell extracts, a CKII buffer
Cloning of the CDV-P gene and purification of system supplemented with PKC cofactors was used since recombinant P protein from E. coli these conditions will readily support both CKII and PKC activity. The volume of cell extract used in these reactions
The phosphoprotein P of negative-strand RNA viruses (1 ml) was established empirically. Reactions were incuis phosphorylated when purified from infected cells (Banbated at 30Њ for 1 hr and resolved by 10% SDS-PAGE erjee et al., 1991; Rima, 1983) . However, when the P followed by autoradiography.
protein of VSV, HPIV3, and MV is expressed in bacteria (E. coli), the recombinant P remains nonphosphorylated In vitro phosphorylation of CDV and MV P using (Barik and Banerjee, 1991; Das et al., 1995b; De et al., exogenous kinase 1995) and is suitable for the in vitro analysis of kinase activities. Therefore, prokaryotic expression of recombi-Recombinant kinases and kinases purified from cells nant P was used to analyze CDV P phosphorylation. other than CV1 were used in the phosphorylation of re-A full-length cDNA clone of the CDV-P gene was gencombinant CDV and MV P protein and recombinant P erated by RT-PCR of genomic RNA purified from nucleoproteins from other negative-strand RNA viruses to supcapsids. The primers were designed to add an NdeI site port results of experiments using CV1 cell extracts. The overlapping the initiator methionine codon AUG, and a enzymes included recombinant CKII (New England Bio-HindIII site 3 to the P gene. This design allowed cloning Labs, Beverly, MA), recombinant PKC-a, recombinant of the RT-PCR product into unique sites in the expression PKC-h, recombinant PKC-z (Goodnight et al., 1995) , and vector. The RT-PCR primers were also designed to add mixed isoforms of PKC isolated from rat brain (Boeha seven-histidine tag to the carboxyl terminus of the reringer Mannheim). A filter-binding assay was used to combinant P protein, facilitating purification of the recomestablish the relative activity of the specific PKC isoforms binant protein by Ni-affinity chromatography. The RT-PCR (i.e., PKC-a, PKC-h, and PKC-z) so that reactions could product migrated as a single 1.6-kb band on a 1% agarbe established containing equivalent activities of each ose gel (data not shown), matching the size of the P gene enzyme. One and two microliters of each recombinant (1631 bp). The structure of the recombinant plasmid (pET-PKC isoform was used under the PKC reaction conditions 17b-CDVP) was confirmed by restriction analysis using described above, using as substrate the synthetic pep-BamHI, in which a 4.0-and 0.91-kb band were visualized tide [Ser 25 ]PKC-(19-31), designated peptide a (Kochs et by ethidium bromide staining (data not shown), matching al., 1993). Peptide a is recognized equally by these PKC the size of restriction fragments predicted from sequence isoforms. Reaction products were spotted onto phosphoanalysis of the CDV P gene and pET-17b vector. cellulose paper, unincorporated radioactivity removed by Expression of recombinant CDV P protein was induced washing in 0.35% phosphoric acid (5 min 1 2), and the by IPTG after the pET-17b-CDVP-transformed DE3 cells degree of peptide phosphorylation measured by liquid were grown to optimal density. When bacterial cell exscintillation counting.
tracts were fractionated on a Ni-affinity column, a prominent doublet with an average molecular mass of 75 kDa In vivo inhibition of protein kinase C activity was observed in fractions 2-7 by 10% SDS-PAGE (data not shown). To further characterize the purified protein, Peptide inhibitors of PKC isoforms were introduced into CV1 cells prior to Ond-CDV infection. Peptide A CDV P-specific hyperimmune serum was used in Western blot analysis of both recombinant P and native P (RKGALRQKN) inhibits conventional PKC isoforms (e.g., PKC-a, PKC-b, and PKC-g). Peptide Z (RRGARRWRK) se-contained in purified nucleocapsid. The same protein doublets of approximately 75 kDa were recognized in lectively inhibits PKC-z activity. These two peptides mediated predominantly by a CKII-like activity, consistent with previously published results (Das et al., 1995b) .
Cell extracts were then fractionated, purifying the kinase activities in order to identify the specific kinases responsible for the observed activity. Crude extracts of CV-1 cells were fractionated through a DE52 column. The recombinant CDV and MV P 0 was phosphorylated by fractions eluted with É0.25 M NaCl (data not shown). bers 25-35, as illustrated in Fig. 2 . The unbound and pooled bound fractions were used in all subsequent exboth preparations, suggesting a similar structure beperiments. The phosphorylation of CDV and MV P by the tween the recombinant and the native P proteins (data unbound fraction was inhibited by 400 nM staurosporine, not shown). The tendency of native P protein of morbilliviwhile 20 mg/ml heparin had no effect on this activity ( Fig.  ruses to migrate as a doublet has been reported (Graves, 3) . Conversely, the kinase activity in peak fraction 30 was 1981; Rima, 1983) . The average size of the P doublet is inhibited by 20 mg/ml heparin while staurosporine had larger than the predicted molecular mass of CDV P (66 no effect (Fig.3) . These data suggested that both PKC kDa). This discrepancy between the observed and the (unbound fraction) and CKII (bound fraction) are involved predicted molecular mass of CDV P has been docuin the phosphorylation of CDV and MV P protein. Phosmented in previous work (Oglesbee et al., 1989a) and is phorylation of MV P by PKC was found to be highly sensisimilar to the aberrant migratory pattern of the VSV P tive to phosphatase activity present in crude cell extracts protein (Barik and Banerjee, 1991).
(data not shown), suggesting a basis for the detection of only minor PKC activities when using crude extract in MV P phosphorylation reactions.
CDV and MV P was phosphorylated by PKC and CKII-
To determine whether phosphorylation by one kinase like activities in CV1 extracts
Crude cytoplasmic extracts and cytoplasmic extracts fractionated by DEAE-cellulose and phosphocellulose chromatography were used to identify the cellular kinase(s) that phosphorylates CDV P and, for comparison, MV P. For these kinase assays, recombinant CDV or MV P 0 protein was mixed with cytoplasmic extract under buffer conditions optimal for both CKII and PKC activity (i.e., CKII buffer supplemented with PKC cofactors), with or without inhibitors of CKII (i.e., heparin) and PKC (i.e., staurosporine). In crude cell extracts, both CDV and MV P were phosphorylated (Fig.1 ). The CDV P phosphorylation was inhibited by 60% in the presence of staurosporine (400 nM) and by 30% in the presence of heparin (20 mg/ ml). Similar results were obtained when using 200 nM staurosporine and 8 mg/ml heparin (data not shown). In contrast, MV P phosphorylation was inhibited by 20% in the presence of staurosporine and by 90% in the pres- MV P 0 phosphorylation, on the other hand, appears to be dylserine, diacylglycerol, and phorbol esters (Bell and Burns, 1991; Nishizuka, 1988 Nishizuka, , 1992 . Atypical PKCs (m, z, and l) are dependent upon phosphatidylserine but are not affected by calcium, diacylglycerol, or phorbol esters (Nishizuka, 1992) . Reactions were supplemented with calcium or the calcium was depleted using 200 mM calcium chloride or 500 mM EGTA, respectively. Phosphatidylserine was added at 100 mg/ml and the diacylglycerol added to a final concentration 100 mg/ml. The kinase activity in the unbound fraction did not require calcium or FIG. 3 . Selective inhibition of kinase activity in unbound and peak diacylglycerol but was stimulated by phosphatidylserine fractions of the phosphocellulose column. The kinase activities within (Fig.4) . These data indicated that the PKC isoform inthe unbound and peak fractions were tested for their sensitivity to inhibition by heparin (H) or staurosporine (S), using recombinant CDV volved in phosphorylation of CDV and MV P belongs to and MV P as substrate under CKII and PKC buffer conditions, respecthe atypical subgroup.
tively. Activities were compared to reactions containing no inhibitors Western blot analysis of the unbound and peak cyto-(0). The phosphorylated ( 32 P-labeled) proteins were analyzed by 10% plasmic fractions was performed to confirm the existence SDS-PAGE and visualized by autoradiography. Kinase activity in the of an atypical PKC in the unbound fraction and CKII in unbound fraction was inhibited by staurosporine but not heparin, consistent with a PKC-like activity. Conversely, kinase activity in the peak the peak fraction. Five PKC isoform-specific polyclonal fraction was inhibited by heparin but not staurosporine, consistent with antibody preparations were used (Gibco BRL), recogniza CKII-like activity. ing a, b1/b2, g, e, and z. In the unbound fraction, specific signal was demonstrated with only the anti-PKC-z antibody (i.e., a double band in which the lower component (i.e., PKC or CKII) influences phosphorylation by the other has an approximate mass of 68 kDa) ( Fig.5 ). Polyclonal kinase, equal amounts of CDV and MV P proteins were antibody against CKII (Yu et al., 1991) detected a 42used in reactions containing unbound and bound cell kDa band in the peak bound fraction (data not shown), fractions, separately or in combination. No synergistic consistent with the mass of CKII and the CKII-like kinase effect was observed when the PKC-and CKII-containing activity detected in this cell fraction. cell fractions were used in combination; phosphorylation by PKC and CKII-like activities occurred independently.
CDV and MV P protein was phosphorylated by Under optimal conditions for PKC and CKII activity, 1.0 exogenous PKC and CKII mol of phosphate was incorporated by the PKC-like activity and 0.3 mol by the CKII activity for each mole of CDV Protein kinase C purified from rat brain (mixed iso-P substrate. The stoichiometry of phosphorylation was forms) and recombinant CKII were used to confirm the established by measuring the degree of 32 P incorporation role of PKC and CKII in mediating phosphorylation of into P, where the specific activity of the [g-32 P]ATP phosrecombinant CDV and MV P. Nonphosphorylated P subphate donor and moles of P protein substrate were destrate from VSV and HPIV3 which are specifically phosfined. In the case of MV, 2.0 mol of phosphate were phorylated by CKII and PKC, respectively, were included incorporated by CKII and 0.1 mol by PKC for each mole as positive controls. The CDV, MV, and HPIV3 P proteins of P substrate (data not shown). Incorporation of less than 1 mol of phosphate per mole of P protein suggests that only a small proportion of the latter becomes phosphorylated.
PKC-z and CKII were detected in cell fractions phosphorylating CDV and MV P
In vitro phosphorylation assays were designed to determine the cofactor requirements of the PKC-like kinase activity in the unbound cytoplasmic fraction to determine which isoform of PKC mediates CDV P phosphorylation. At least 11 isoforms of PKC have been identified in mam- al., 1994; Nishizuka, 1992) . Amongst them, a, b1, b2, CDV or MV P in presence (/) or absence (blank) of one or more of and g are designated conventional PKCs and are actithe following: CaCl 2 (200 mM), PS (100 mg/ml), DAG (20 mg/ml), and vated by calcium, phosphatidylserine, diacylglycerol, and EGTA (500 mM). The kinase activity in the unbound fraction was stimuphorbol esters. Novel PKCs (u, h, e, and d ) do not require lated by phosphatidylserine and was not dependent upon Ca 2/ or diacylglycerol, consistent with an atypical PKC. calcium for activation, but are stimulated by phosphati- were phosphorylated by purified PKC (Fig. 6) , and stauroisoforms a, h, and z were combined with recombinant CDV or MV P sporine (400 nM) inhibited the PKC activity. Recombinant in reactions containing [g-32 P]ATP and using PKC buffer conditions. The phosphorylated proteins were resolved by 10% SDS-PAGE and CKII phosphorylated the P protein of CDV, MV, and VSV visualized by autoradiography. For each reaction, the 75-kDa CDV P consistent with the kinase activity observed in the phosprotein is labeled to a degree proportionate to bands of lower molecular phocellulose bound fraction. The phosphorylation was mass, suggesting that the latter represent degradation products of the inhibited by heparin at 20 mg/ml. The lesser degree of parental protein.
heparin-mediated inhibition of VSV and MV P phosphorylation may reflect a higher affinity of CKII for these recommined the relative activity of these enzymes in a filter binant viral proteins.
binding assay using their common pseudosubstrate, Recombinant PKC isoforms were used to support the peptide a. The degree of peptide a phosphorylation, specific role of PKC-z in CDV and MV P phosphorylation. measured by liquid scintillation counting, is used to de-Using recombinant a, h, and z isoforms, we first detertermine the relative activity of PKC isoform preparations. The relative activity, by volume, of a, h, and z isoforms was 3.5:1.0:11.4. This determination allowed the design of subsequent reactions containing equivalent enzymatic activities and recombinant CDV or MV P protein as substrate. CDV and MV P were phosphorylated by PKC-z, with lesser degrees of phosphorylation mediated by PKCh and PKC-a (Fig. 7) . These results further support the involvement of PKC-z in CDV and MV P phosphorylation.
In situ inhibition of PKC-z eliminates CDV replication
For VSV, RSV, and HPIV3, phosphorylation of P is proposed as an essential step in the activation of the viral polymerase (L) (Barik and Banerjee, 1991, 1992; De et FIG. 6. Phosphorylation of recombinant CDV and MV P by recombi-al., 1995; Mazumder and Barik, 1994) . Accordingly, in situ nant CKII and purified PKC (mixed isoforms). Reactions were performed inhibition of PKC-z activity eliminates HPIV3 but not VSV in the presence of heparin (H) or staurosporine (S), or in the absence replication, the latter being dependent upon CKII for P of either inhibitor (0), to confirm the specificity of phosphorylation mediphosphorylation (De et al., 1995) . In the present study, ated by the purified kinases. Recombinant P protein from HPIV3 was pseudosubstrate peptide inhibitors of PKC-z (peptide Z) used as a positive control for PKC reactions, and recombinant P protein from VSV was used as positive controls for CKII reactions. and conventional PKCs (peptide A) were used to deter-mine whether the PKC-z activity is relevant to CDV replication. These inhibitory peptides mimic PKC autoinhibitory regions known as pseudosubstrate domains. Peptide A has a sequence conserved in the pseudosubstrate domain of PKC isotypes a, b, and g and is an inhibitor of these isotypes when introduced into cells (Dominguez et al., 1992) . Peptide Z has a sequence identical to the pseudosubstrate domain of PKC-z, being sufficiently different from the pseudosubstrate domains of PKC a, b, and g to mediate selective inhibition of PKC-z within cells (Dominguez et al., 1992) . First, these two peptides (i.e., peptide A and Z) were used at varying concentrations (5-20 mM) in the in vitro phosphorylation of CDV P by phosphocellulose unbound cell fraction. Peptide Z inhibited phosphorylation of CDV P by more than 70% at 20 mM, whereas peptide A had no effect. Next these peptides were delivered at varying concentrations into subconfluent monolayers of CV1 cells using a lipid-based (data not shown). The effect of peptide treatment on infectious viral progeny release was consistent with these results (Fig. 8 ). Virus harvested from cells treated with 1 CDV and MV P contain multiple PKC consensus recognition sites (S/T-X-K/R; n Å 8 for Ond-CDV and n Å 7 for mM peptide Z yielded 1200 PFU/1.5 1 10 5 cells, comparable to viral progeny release from infected cells treated Edmonston MV). Using fractionated cell extracts (Figs. 2-5) , we demon-with 1-5 mM peptide A or untreated controls. At 2 mM peptide Z, viral progeny release was decreased by 53% strate involvement of an atypical PKC in the phosphorylation of both CDV and MV P proteins. Protein kinase C-z and at 3 mM peptide Z viral progeny release was completely abolished. Peptide Z treatment did not affect via-was present in cell fractions containing the atypical PKC activity based upon biochemical and antigenic analyses. bility of uninfected control cells.
Furthermore, both native PKC (mixed isoforms; Fig. 6 ) and recombinant PKC-z ( Fig. 7 ) phosphorylate CDV and DISCUSSION MV P to a high degree of activity. Previous analysis of MV P phosphorylation by native kinase, however, failed We have demonstrated involvement of two cellular kinases, CKII and PKC-z, in the phosphorylation of CDV P to detect PKC activity when using crude cytoplasmic extracts (Das et al., 1995b ). In the current study, the atypical protein. Of the two kinases, PKC was detected as the major and CKII as the minor activities in CDV P phosphor-PKC activity against MV P was readily detected only after these crude preparations were further refined by ion-ylation by crude cell extracts (Fig.1) . In contrast, MV P phosphorylation was carried out predominantly by CKII, exchange chromatography. The disparity between results of using crude versus fractioned cell extracts ap-as reported previously (Das et al., 1995b) . In the latter work, CKII phosphorylation of MV P protein was shown pears to reflect the presence of phosphatase activity in the crude extract. using both native enzyme contained in crude cell extracts and recombinant CKII (Das et al., 1995b) . In this regard,
The biological relevance of PKC-z phosphorylation of CDV P was supported by results of experiments using phosphorylation of CDV and MV P differs despite the biochemical similarity between these two proteins. The isoform-specific inhibition of PKC-z activity (Fig. 8) . Peptide Z, an inhibitor of PKC-z, inhibited in vitro CDV P amino acid sequences of the CDV and MV P proteins are 44% identical (Hall et al., 1980; Yamanaka et al., 1992) , phosphorylation by fractionated cell extracts and caused a dosage-dependent reduction in CV1 permissiveness to and both share multiple CKII consensus recognition sites (S/T-X-X-D/E; n Å 10 for Ond-CDV and Edmonston MV).
CDV replication. Peptide A, an inhibitor of conventional PKC isoforms, had no effect in either of these assays. In addition, the deduced amino acid sequences of both Other reports document the ability of peptide Z to reduce Vero, Madin-Darby canine kidney, Madin-Darby bovine kidney, porcine kidney, and murine neuroblastoma cells the in vitro activity of recombinant PKC-z, where peptide A has no effect (De et al., 1995) . Furthermore, peptide Z (unpublished observation). Thus, the expression of PKCz complements the broad cellular and tissue tropism of inhibits HPIV3 replication when administered to CV 1 cells (De et al., 1995) . The specificity of peptide Z for PKC CDV, suggesting that cellular PKC-z activity is an important determinant of permissiveness to CDV infection. and HPIV3/CDV replication is documented by the lack of effect of peptide Z upon replication of VSV, a virus using CKII for the phosphorylation activation of P (De et al., ACKNOWLEDGMENTS 1995) . Down-regulation of PKC-z does not affect meta-
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